A Manni, YW Sun, TD Schell, T Lutsiv,
H Thompson… - Pharmaceuticals, 2023 - mdpi.com
Immunotherapy targeting program cell death protein 1 (PD-1) in addition to chemotherapy
has improved the survival of triple-negative breast cancer (TNBC) patients. However, the …